期刊
CANCER LETTERS
卷 161, 期 1, 页码 63-71出版社
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3835(00)00600-5
关键词
estrogen receptor beta; thymidylate synthase; survivin; telomerase; colon cancer
类别
Estrogen receptor beta (ER beta) mediated system was tested in three colon cancer cell lines with different sensitivities. These cell lines express ER beta and androgen receptor (AR) but not the classic estrogen receptor ER alpha. Combinations of ER beta ligands such as estradiol (E-2), 17 epiestriol (17E(3)), quercetin (Q with tamoxifen (TMX) showed marked growth inhibition. The IC50 were: 2.0 +/- 0.3 x 10(-15), 3.0 +/- 1.3 x 10(-10) and 1.2 +/- 0.5 x 10(-14) M for DLD-1, DLD-1/5FU and DLD-1/FdUrd. respectively (TMX + E-2 treatment, mean +/- SD, n = 3). The IC50 of TMX + 17E(3) were 3.5 +/- 1.8 x 10(-8), 2.6 +/- 0.9 x 10(-8) and 1.4 +/- 1.1 x 10(-14) M and that of TMX + Q treatment were 3.4 +/- 2.1 x 10(-9), 3.6 +/- 0.2 x 10(-9) and 2.6 +/- 1.1 x 10(-9) M, respectively. This inhibition was significantly different from single agent treatment at the probability level of P < 0.002. Thymidylate synthase expression and survivin expression were also markedly inhibited. The inhibition was highest with TMX + Q and lowest with TMX + dehydroepiandrosterone (DHEA). The expression of telomerase was also inhibited by TMX but combination with ER agonists reversed the inhibition. The cellular sensitivity to 5FU was increased: TMX + E-2, TMX + 17E(3) and TMX + Q were 1.7 +/- 0.5 x 10(-5), 8.4 +/- 3.2 x 10(-8), 8.2 +/- 2.9 x 10(-8) and 6.3 +/- 3.3 x 10(-8) M for DLD-1 cells and 7.7 +/- 4.8 x 10(-5), 9.1 +/- 4.9 x 10(-7), 1.5 +/- 0.3 x 10(-9) and 5.7 +/- 2.2 x 10(-8) M for DLD-1/5FU. DLD-1/FdUrd cells had IC50 of 8.5 +/- 6.1 x 10(-5), 1.8 +/- 0.8 x 10(-8), 37 +/- 1.1 x 10(-9) and 1.6 +/- 1.1 x 10(-9) M (mean +/- SD) for the control, TMX + E-2, TMX + 17E3 and TMX + Q. The present data indicate that ERP ligands in combination with TMX may have tumor static effects on colon cancer cells. (C) 2000 Elsevier Science Ireland Ltd. Ail rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据